<DOC>
	<DOCNO>NCT01451346</DOCNO>
	<brief_summary>This randomize , double blind , fix dose , placebo control , parallel-group pilot study obtain data size variance treatment effect subject mild moderate Psoriasis .</brief_summary>
	<brief_title>Study Patients With Mild Moderate Psoriasis</brief_title>
	<detailed_description>This randomize , double blind , fix dose , placebo control , parallel-group pilot study obtain data size variance treatment effect subject mild moderate Psoriasis . The target sample size 60 select practical figure recruitment purpose one centre 3 months.After 2 week washout emollient apply psoriasis , patient attend baseline assessment psoriasis severity blood tests.Subjects attend every 4 week 12 week clinical assessment blood tests.Each patient eligible { see inclusion &amp; exclusion criterion } allocate either active treatment placebo identical packing total 12 week .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects diagnose mild moderate psoriasis define clinician , Has Psoriasis Area Severity Index { PASI } less 20 , Male female subject , Aged 1860 year age , Nonpregnant female must agree use adequate method contraception study , Is capable give write informed consent prior study entry , Be willing refrain take dietary supplement food contain fermented live bacteria within 1 month prior treatment study , Have participate clinical drug study use investigational new drug past previous 30 day , Clinical Chemistry haematology result Visit 1 within normal limit , Be willing refrain use topical psoriactic cream 2 week prior treatment study . Are less 18 year age , 60 year age , History sensitivity lactose [ eg , lactose intolerance ] dairy product , History consumption probiotics,1 month prior treatment , Being treat steroid 2 week prior entry , Diseases gastrointestinal tract , liver , pancreas biliary tree [ eg ; gastritis , symptomatic gall stone , duodenal ulcer , gastroenteritis , diverticulitis . ] Exceptions include haemorrhoid , hiatus hernia asymptomatic gall stone . History major gastric , hepatic , pancreatic intestinal surgery perforation , exclude cholescystectomy , appendicectomy , haemorrhoidectomy polypectomy . Recent unexplained rectal bleed and/or significant unexplained weight loss . Antibiotic use within one month prior Visit 1. significant acute chronic coexist illness { cardiovascular , gastrointestinal , immunological } condition , contraindicates , investigator judgement entry study . Patients Diabetes Mellitus . Individuals , opinion investigator , consider poor clinical attendee unlikely reason able comply trial . Subjects currently receive treatment involve experimental drug . If subject recent experimental trial , must less 30 day prior study . Have concomitant end stage organ disease eg ; cardiovascular , hepatic , pulmonary , renal , , Investigators judgement , contraindicate participation study . Have history malignancy past 5 year exception Basal Cell Carcinoma . Evidence alcohol drug abuse . Evidence unstable form psoriasis , include guttate , erthrodermic , exfoliative pustular psoriasis . Evidence inflammatory skin disease may confound evaluation psoriasis . Has systematic antipsoriatic treatment PUVA therapy within previous 4 week . Subject UVB therapy previous 2 week . If subject score &gt; 20 % PASI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Pilot study</keyword>
</DOC>